Source: Shock. Unidades: FMRP, FM, ICB
Subjects: FARMACOLOGIA, LIPOPOLISSACARÍDEOS, CARBOIDRATOS, LEUCÓCITOS, CÉLULAS ENDOTELIAIS, CAMUNDONGOS, INFLAMAÇÃO, NEUTRÓFILOS
ABNT
TREVELIN, Silvia Cellone et al. Endothelial Nox2 limits systemic inflammation and hypotension in endotoxemia by controlling expression of Toll-Like Receptor 4. Shock, v. 56, n. 2, p. 268–277, 2021Tradução . . Disponível em: https://doi.org/10.1097/shk.0000000000001706. Acesso em: 31 out. 2024.APA
Trevelin, S. C., Sag, C. M., Zhang, M., Alves Filho, J. C. F., Cunha, T. M., Santos, C. X. dos, et al. (2021). Endothelial Nox2 limits systemic inflammation and hypotension in endotoxemia by controlling expression of Toll-Like Receptor 4. Shock, 56( 2), 268–277. doi:10.1097/shk.0000000000001706NLM
Trevelin SC, Sag CM, Zhang M, Alves Filho JCF, Cunha TM, Santos CX dos, Sawyer G, Murray T, Brewer A, Laurindo FRM, Protti A, Lopes LR, Ivetic A, Cunha FQ, Shah AM. Endothelial Nox2 limits systemic inflammation and hypotension in endotoxemia by controlling expression of Toll-Like Receptor 4 [Internet]. Shock. 2021 ; 56( 2): 268–277.[citado 2024 out. 31 ] Available from: https://doi.org/10.1097/shk.0000000000001706Vancouver
Trevelin SC, Sag CM, Zhang M, Alves Filho JCF, Cunha TM, Santos CX dos, Sawyer G, Murray T, Brewer A, Laurindo FRM, Protti A, Lopes LR, Ivetic A, Cunha FQ, Shah AM. Endothelial Nox2 limits systemic inflammation and hypotension in endotoxemia by controlling expression of Toll-Like Receptor 4 [Internet]. Shock. 2021 ; 56( 2): 268–277.[citado 2024 out. 31 ] Available from: https://doi.org/10.1097/shk.0000000000001706